Products and Education designed to minimize risk and maximize
outcomes
LIMERICK, Pa., Dec 10, 2010 (BUSINESS WIRE) --
Teleflex Incorporated will showcase a number of anesthesia
products designed to help providers minimize risk and maximize outcomes
for their patients at the 64th PostGraduate Assembly in Anesthesia (PGA)
of The New York State Society of Anesthesiologists at the New York
Marriott Marquis Hotel on December 10-14, 2010. These products include:
- Arrow(R) StimuCath(R) Safety Kits: StimuCath Safety Kits are
designed to
help facilities be more compliant with OSHA and JCAHO
guidelines by
including Sharps SafetyGlide(R)injection
needles, locking Sharps Away II(TM)cup and medication labels
combined with StimuCath, the #1 selling stimulating peripheral nerve
block catheter in North America. StimuCath's wire-coil helix allows
for accurate placement of block using stimulation and/or ultrasound.
This unique catheter aids in improving block success by allowing
physicians to confirm catheter location before, during and after
placement.
- Arrow FlexTip Plus(R) Epidural Catheter: With its unique
wire-embedded polyurethane design, the FlexTip Plus is the only
epidural catheter clinically proven to minimize the risk of
intravascular cannulation1,2,3 and effectively reduce
transient paresthesia.4
- Arrow SureBlock(TM) Spinal Anesthesia Trays: Safety-engineered
in compliance with the latest guidelines from OSHA and JCAHO,
SureBlock trays feature the Sprotte(R) Spinal Needle. The Sprotte
Spinal Needle, with its special polished finish, has been clinically
proven to significantly reduce postdural puncture headaches.5, 6,
7, 8
Educational Opportunities
Teleflex is dedicated to supporting physicians and advancing the
practice of regional anesthesia through its clinical education program.
At the PGA meeting on Friday, December 10, 2010 from 5:30- 8:00pm at the
Marriott Marquis- Empire Complex, 7th Floor, Teleflex will
host up to 150 physicians at a Corporate non-CME Educational Update
Dinner Symposium: "Peripheral Nerve Blocks in Surgery--Improving Patient
Outcomes". The speaker for this program is Dr. Krishna Boddu, MBBS, MD,
DNB, FANZCA. Dr. Boddu is the Associate Professor, Department of
Anesthesiology, Director- Division of Orthopaedic Anesthesia, Regional
Anesthesia & Acute Pain Medicine Fellowship Program and Director,
Regional Anesthesia & Acute Pain Medicine at The University of Texas
Medical School at Houston & Memorial Hermann Hospital.
Additionally, Teleflex has partnered with several facilities throughout
the United States to allow physicians to observe all aspects of
establishing and running peripheral nerve block and acute pain
management programs. Teleflex also sponsors a Pain Management Center of
Excellence, which allows physicians to gain hands-on peripheral nerve
block training at a world-class teaching institution.
All of these educational programs provide training on Teleflex's Arrow
brand of regional anesthesia products.
"We look forward to presenting and meeting customers at the PGA as we
build on our efforts to support physicians with products and education
to address the concerns anesthesiologists face daily," said Cary Vance,
Executive Vice President, Teleflex, North America. "Teleflex is pleased
to continue to work with the anesthesia industry as a trusted resource
and partner."
For more information on the Teleflex's anesthesia products and
educational programs, visit www.teleflex.com.
About Teleflex Incorporated
Teleflex Incorporated (NYSE: TFX) is a global provider of medical
technology products that enable healthcare providers to improve patient
outcomes, reduce infections and support patient and provider safety.
Teleflex, which employs approximately 12,800 people worldwide, also has
niche businesses that serve segments of the aerospace and commercial
markets with specialty engineered products. Additional information about
Teleflex can be obtained from the company's website at www.teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Arrow, Sharps Away II, StimuCath, SureBlock and FlexTip Plus are
trademarks or registered trademarks of Teleflex Incorporated or its
affiliates. SafetyGlide is a registered trademark of Becton, Dickinson
and Company. Sprotte is a registered trademark of Pajunk GmbH LTD.
1. Mhyre, Jill M., et al. A Systematic Review of Randomized Controlled
Trials That Evaluate Strategies to Avoid Epidural Vein Cannulation
During Obstetric Epidural Catheter Placement. Anesthesia & Analgesia
2009; 108 (4): 1232-1242.
2. Banwell B.R., et al. Decreased incidence of complications in patients
with the Arrow (FlexTip Plus(TM)) epidural catheter. Canadian Journal of
Anaesthesia 1998; 45 (4): 370-372.
3. Cohen S., et al. Sutured Epidural Catheter for Epidural Block in
obstetric Patients: "Arrow" versus "B. Braun". Anesthesiology 2006;105:
A904.
4. Cohen S., et al. Arrow versus B. Braun Epidural Catheter for Epidural
Block in Obstetric Patients. Anesthesiology 2004; 101: A1199.
5. Toyka KV, Müller B, Reichmann H, Strupp M, Schüler O, Brandt T.
"Atraumatic" Sprotte needle reduces the incidence of post-lumbar
puncture headaches. Neurology 2002; 59: 1120-21.
6. Pittoni G, Toffoletto F, Calcarella G, Zanette G, Giron GP. Spinal
anesthesia in outpatient knee surgery: 22-gauge versus 25-gauge Sprotte
needle. Anesth. Analg. 1995; 81: 73-9.
7. Pajunk Sprotte cannula product brochure
8. Jäger H, Schimrigk K, Haab A. Post lumbar puncture headache
prevention by means of an atraumatic needle. Akt Neurol. 1991;
18:61-4.
SOURCE: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze, Vice President Investor Relations
610-948-2836